Nozma ODT 5 mg (Dispersible Tablet)
Unit Price: ৳ 7.50 (3 x 10: ৳ 225.00)
Strip Price: ৳ 75.00
Medicine Details
Category | Details |
---|---|
Generic | Montelukast sodium |
Company | Novatek pharmaceuticals ltd |
Also available as |
Title
- Nozma ODT 5 mg Tablet
Categories
- Asthma Medication
- Allergic Rhinitis Medication
- Leukotriene Receptor Antagonist
Description
- Nozma ODT is indicated for prophylaxis and chronic treatment of asthma, acute prevention of Exercise-Induced Bronchoconstriction (EIB), and relief of symptoms of Allergic Rhinitis (AR) including seasonal and perennial allergic rhinitis.
- Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT1).
- Dosage varies for adults, adolescents, and pediatric patients based on age and condition. Nozma ODT is not indicated for use in the reversal of bronchospasm in acute asthma attacks and it should not be abruptly substituted for inhaled or oral corticosteroids.
- Common side effects include diarrhea, fever, headache, nausea, vomiting, and skin reactions. Uncommon side effects include anxiety, depression, dizziness, and sleep disorders. Rare side effects include angioedema, hallucination, memory loss, and suicidal tendencies.
- Nozma ODT has therapeutic class as leukotriene receptor antagonists. It is contraindicated in patients who are hypersensitive to any component of this product. Nozma ODT should be stored in a cool & dry place below 30°C and protected from light & moisture.
Dimensions
- Tablet Size: 5 mg
Color options
Functions
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis (AR) including seasonal and perennial allergic rhinitis
Materials
Technical specifications
- Molecular Formula: C35H36ClNO3S
- Chemical Structure: Image available
Design elements
- Orally disintegrating tablet (ODT)
Usability features
- Dosage varies for different age groups and conditions
- Nozma ODT should not be used as monotherapy for the treatment and management of exercise induced bronchospasm
- Appropriate rescue medication should be available
- Therapy with Nozma ODT can be continued during acute exacerbations of asthma
Storage
- Store in cool & dry place below 30°C
- Protect from light & moisture
- Keep out of reach of children
Pharmacology
- Montelukast inhibits the cysteinyl leukotriene receptor (CysLT1)
- Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma & allergic rhinitis
- Correlated with airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process
Interactions
- Administered with other therapies used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions
- No clinically important effects on the pharmacokinetics of several drugs such as theophylline, prednisone, oral contraceptives, terfenadine, digoxin, and warfarin
Contraindications
- Contraindicated in patients who are hypersensitive to any component of this product
Side effects
- Common: Diarrhea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection
- Uncommon: Anxiety, depression, dizziness, sleep disorders
- Rare: Angioedema, hallucination, hepatic disorders, memory loss, suicidal tendencies
Pregnancy lactation
- Use during pregnancy only if clearly needed
- Caution should be exercised when given to a nursing mother
Precautions warnings
- Not indicated for use in the reversal of bronchospasm in acute asthma attacks
- Appropriate rescue medication should be available
- Should not be abruptly substituted for inhaled or oral corticosteroids
- Not to be used as monotherapy for the treatment and management of exercise induced bronchospasm
- Caution for patients with known aspirin sensitivity
Overdose effects
- Adverse experiences consistent with the safety profile of the product
- Usual supportive measures recommended in the event of overdose
Commonly asked questions
- What is Nozma ODT 5 mg DT?: Nozma ODT 5 mg DT is a selective and orally active leukotriene receptor antagonist
- What is Nozma ODT 5 mg DT used for?: Commonly used to treat asthma or allergic rhinitis. It helps keep airways open and easy breathing by blocking leukotrienes
- How soon can the effect be observed?: After 1-3 hours of administration. Not a fast-acting rescue medicine for asthma attacks and needs to be taken daily to work properly
- How long does the effect last?: Lasts for an average duration of 24 hours
- Should I use Nozma ODT 5 mg DT empty stomach?: May be taken with or without food as prescribed by the doctor
- What if I miss a dose?: If you miss a dose, take it as soon as possible. Do not double up on doses
- Are there any pregnancy warnings?: Use in pregnant women should be avoided unless clearly needed
- General Instructions:
- Take Nozma ODT 5 mg DT exactly as prescribed
- Avoid situations or activities that may trigger an asthma attack
- Talk to your doctor before using if pregnant or breastfeeding
Related Brands
- Aeron FT 4 mg (Dispersible Tablet) - healthcare-pharmaceuticals-ltd
- Aeron FT 5 mg (Dispersible Tablet) - healthcare-pharmaceuticals-ltd
- Aeron 10 mg (Tablet) - healthcare-pharmaceuticals-ltd
- Montinex 4 mg (Chewable Tablet) - beacon-pharmaceuticals-plc
- Montinex 5 mg (Chewable Tablet) - beacon-pharmaceuticals-plc